HOME >> BIOLOGY >> NEWS
Landmark agreement between Samoa and UC Berkeley could help search for AIDS cure

Apia, Samoa - The University of California, Berkeley, has signed an agreement with the Samoan government to isolate from an indigenous tree the gene for a promising anti-AIDS drug and to share any royalties from sale of a gene-derived drug with the people of Samoa.

The agreement, announced today (Thursday, Sept. 30) in Apia, the capital of Samoa, supports Samoa's assertion of national sovereignty over the gene sequence of Prostratin, a drug extracted from the bark of the mamala tree (Homalanthus nutans). The drug currently is being studied by scientists around the world because of its potential to force the AIDS virus out of hibernation in the body's immune cells and into the line of fire of anti-AIDS drugs now in use.

"Prostratin is Samoa's gift to the world," explained Samoan Minister of Trade Joseph Keil. "We are pleased to accept the University of California as a full partner in the effort to isolate the Prostratin genes."

Despite Prostratin's promise as an anti-AIDS drug, its supply is limited by the fact that the drug has to be extracted from the bark and stemwood of the mamala tree. Researchers in the laboratory of Jay Keasling, UC Berkeley professor of chemical engineering, plan to clone the genes from the tree that naturally produce Prostratin and insert them into bacteria to make microbial factories for the drug. A similar technology is currently being explored to produce the anti-malarial drug artemisinin.

"A microbial source for Prostratin will ensure a plentiful, high-quality supply if it is approved as an anti-AIDS drug," said Keasling, who also is a faculty affiliate with the California Institute for Quantitative Biomedical Research (QB3) and head of the Synthetic Biology Department at Lawrence Berkeley National Laboratory. "We consider the actual gene sequences as part of Samoa's sovereignty, and every effort will be made to reflect this fact."

The agreement, signed by Prime Minister Tuila'epa Aiono Sailele M
'"/>

Contact: Robert Sanders
rls@pa.urel.berkeley.edu
510-643-6998
University of California - Berkeley
30-Sep-2004


Page: 1 2 3

Related biology news :

1. Landmark gene agreement announced by Samoan government and UC Berkeley for anti-AIDS drug Prostratin
2. Landmark, pivotal Phase IIb/III trial of biotoxin for cancer pain begins
3. Landmark conference for United Nations on human cloning and stem cell research
4. Landmark study offers new information about breast cancer genes
5. Landmark completion of comprehensive index of human proteins to be presented at New York Academy of Sciences
6. Radical discovery dedicated a National Historic Chemical Landmark
7. Landmark obesity study
8. Landmark progress in understanding ribosome structure-- research done at Brookhaven Labs light source
9. NSF and AIBS sign cooperative agreement for NEON project office
10. UN report: Accelerate global agreement to oversee exploitation of South Pole extremophiles
11. Cyrospace, University of Houston sign commercialization agreement

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 03, 2019 , ... R3 Stem Cell is ... nationwide Centers of Excellence. R3 wants patients to feel secure when they make ... patients from Centers that use inferior regenerative biologics, protocols or amounts, R3 provides ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the development of biosimilars, the broad definition ... this task. Despite this uncertainty, several manufacturers have been successful and numerous follow-on biologics ... of this webinar, learn how analytical similarity is achieved in biosimilars based on recently ...
(Date:3/29/2019)... ... March 29, 2019 , ... ... biomanufacturing systems, will attend the Society for Biomaterials Annual Meeting & Exposition on ... opportunity to connect with academic, healthcare, governmental and business professionals in all aspects ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive ... dialogue, today announces its Boston CEO conference to be held May 28-29, 2019 ... and opportunities with high-level panels and discussions from past, present and future change-makers. ...
(Date:3/27/2019)... , ... March 26, 2019 , ... A leader in ... cell services to veterinarians across the United States and Canada since 2004. The ... and soft tissue injuries in the dog, cat, and horse. Recently, VetStem ...
(Date:3/27/2019)... ... March 27, 2019 , ... Lachman is sponsoring the ... Clayton Hotel Burlington Road, Dublin, Ireland. The executive team on site will be available ... two key tracks on the agenda this year. , Executives from Lachman participating at ...
(Date:3/23/2019)... (PRWEB) , ... March 22, 2019 , ... ... its LenS3 Multi-Angle Light Scattering (MALS) detector , offering a revolutionary approach ... synthetic polymers, polysaccharides, proteins, and biopolymers. A novel optical design, a unique cell-block ...
Breaking Biology Technology:
Cached News: